Other potential strategies for targeting muting mutant p53 include the use of PROTACs/molecular glues which can lead to degradation of specific mutant proteins [101], induction of therapeutic hypothermia in tumors possessing temperature sensitive TP53 mutations [100] and exploitation of synthetic lethality for cancer containing gain of function mutations [99]. Here, TP53 is linked to cancer.